Published in BMJ Open on February 16, 2012
Disparities experienced by Aboriginal compared to non-Aboriginal metropolitan Western Australians in receiving coronary angiography following acute ischaemic heart disease: the impact of age and comorbidities. Int J Equity Health (2014) 0.77
Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction: a matched cohort study. BMC Cardiovasc Disord (2016) 0.75
Risk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. World J Cardiol (2014) 0.75
Disparities in a provision of in-hospital post-arrest interventions for out-of-hospital cardiac arrest (OHCA) in the elderly population-protocol for a systematic review. Syst Rev (2016) 0.75
Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome. Neth Heart J (2017) 0.75
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet (1996) 8.50
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2005) 2.94
Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol (2007) 2.03
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J (2008) 1.86
The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv (2003) 1.63
Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome. Arch Cardiovasc Dis (2009) 1.54
2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med (2007) 1.49
Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J (2004) 1.19
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J (2006) 1.18
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database Syst Rev (2010) 1.03
Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J (2006) 0.99
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol (2009) 0.98
Elderly people with multi-morbidity and acute coronary syndrome: doctors' views on decision-making. Scand J Public Health (2009) 0.89
Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation. Am Heart J (2008) 0.87
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. Eur Heart J (2008) 0.83
Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome. Am J Cardiol (2009) 0.78
Acute myocardial infarction. Lancet (2008) 3.59
Bare metal stent restenosis is not a benign clinical entity. Am Heart J (2006) 3.39
Intravenous platelet blockade with cangrelor during PCI. N Engl J Med (2009) 3.31
Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med (2009) 2.52
Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv (2011) 2.08
Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv (2005) 2.00
Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J (2013) 1.77
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol (2007) 1.59
Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation (2002) 1.58
Balloon aortic valvuloplasty to bridge and triage patients in the era of trans-catheter aortic valve implantation. Catheter Cardiovasc Interv (2012) 1.57
Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation (2003) 1.55
Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust (2010) 1.52
Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv (2004) 1.50
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) (2015) 1.49
Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study. Catheter Cardiovasc Interv (2012) 1.39
Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study). Am J Cardiol (2002) 1.37
Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol (2009) 1.31
Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol (2004) 1.15
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol (2004) 1.06
A randomised study of three different informational AIDS prior to coronary angiography, measuring patient recall, satisfaction and anxiety. Heart Lung Circ (2007) 1.05
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. Am Heart J (2012) 1.04
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol (2007) 1.04
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. Am J Cardiol (2004) 0.96
Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm (2011) 0.91
Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med (2005) 0.90
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol (2003) 0.90
Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. J Am Coll Cardiol (2002) 0.89
Variations in the application of cardiac care in Australia. Med J Aust (2008) 0.88
Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation (2004) 0.86
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol (2004) 0.85
QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure. J Am Soc Echocardiogr (2006) 0.84
Cardiac MRI assessment of left and right ventricular parameters in healthy Australian normal volunteers. Heart Lung Circ (2008) 0.84
Impact of female sex on outcome after percutaneous coronary intervention. Am Heart J (2004) 0.84
Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population. Int J Cardiol (2012) 0.83
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol (2002) 0.83
Coronary artery wall thickness of the left anterior descending artery using high resolution transthoracic echocardiography--normal range of values. Echocardiography (2013) 0.83
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. Kardiol Pol (2015) 0.82
Assessment of early diastolic left ventricular function by two-dimensional echocardiographic speckle tracking. Eur J Echocardiogr (2008) 0.81
2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006. Med J Aust (2008) 0.80
Treatment disparities and effect on late mortality in patients with diabetes presenting with acute myocardial infarction: observations from the ACACIA registry. Med J Aust (2009) 0.80
High-resolution transthoracic echocardiography of the left anterior descending coronary artery: a novel noninvasive assessment of coronary vasoreactivity. J Am Soc Echocardiogr (2007) 0.80
Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis. Med J Aust (2012) 0.80
Lost in translation: health resource variability in the achievement of optimal performance and clinical outcome. Circ Cardiovasc Qual Outcomes (2011) 0.79
The role of antiplatelet therapy in the secondary prevention of coronary artery disease. Curr Opin Cardiol (2010) 0.79
Changes in left anterior descending coronary artery wall thickness detected by high resolution transthoracic echocardiography. Am J Cardiol (2008) 0.79
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiol Haemost Thromb (2008) 0.79
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. J Am Coll Cardiol (2004) 0.78
Outcomes of cardiac surgery in Indigenous Australians. Med J Aust (2009) 0.78
Pre-Disposing and Precipitating Factors in Men With Spontaneous Coronary Artery Dissection. JACC Cardiovasc Interv (2016) 0.78
Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents. Curr Opin Cardiol (2010) 0.78
Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions. Expert Opin Pharmacother (2002) 0.77
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study. Am Heart J (2007) 0.77
Predictors of statin-induced regression of left anterior descending coronary artery wall thickness as measured by high-resolution transthoracic echocardiography. Echocardiography (2012) 0.77
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) (2016) 0.76
Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis. J Blood Med (2013) 0.76
Bivalirudin in percutaneous coronary intervention. Vasc Health Risk Manag (2006) 0.76
The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention. Am Heart J (2005) 0.76
Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency department. Heart Lung Circ (2013) 0.76
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial. Am J Cardiol (2003) 0.75
Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size. Int J Cardiol (2011) 0.75
Characteristics of Extension and De Novo Recurrent Spontaneous Coronary Artery Dissection. EuroIntervention (2017) 0.75
Effects of tirofiban on hemostatic activation and inflammatory response during cardiopulmonary bypass. Am J Cardiol (2003) 0.75
Should fee-for-service be for all guideline-advocated acute coronary syndrome (ACS) care? Observations from the Snapshot ACS study. Aust Health Rev (2015) 0.75
Tissue Doppler derived mechanical dyssynchrony does not change after cardiac resynchronization therapy. Echocardiography (2011) 0.75
Catheter-Induced Iatrogenic Coronary Artery Dissection in Patients With Spontaneous Coronary Artery Dissection. JACC Cardiovasc Interv (2016) 0.75
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol (2002) 0.75
Is There Inequity in Hospital Care Among Patients With Acute Coronary Syndrome Who Are Proficient and Not Proficient in English Language?: Analysis of the SNAPSHOT ACS Study. J Cardiovasc Nurs (2016) 0.75
Re-infarction after primary percutaneous coronary intervention. Curr Opin Cardiol (2015) 0.75
Expertise and infrastructure capacity impacts acute coronary syndrome outcomes. Aust Health Rev (2017) 0.75
Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. Am J Med (2003) 0.75
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. Am Heart J (2002) 0.75
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. Am J Cardiol (2003) 0.75